Predictive markers in breast cancer: An update on ER and HER2 testing and reporting.
about
Translational progress on tumor biomarkersDirect estrogen receptor (ER) / HER family crosstalk mediating sensitivity to lumretuzumab and pertuzumab in ER+ breast cancer.Novel panel of protein biomarkers to predict response to bortezomib-containing induction regimens in multiple myeloma patients.Impact of Modified 2013 ASCO/CAP Guidelines on HER2 Testing in Breast Cancer. One Year Experience.Association of five single nucleotide polymorphisms at 6q25.1 with breast cancer risk in northwestern ChinaAssociation between dietary inflammatory potential and breast cancer incidence and death: results from the Women's Health Initiative.Analysis of molecular markers as predictive factors of lymph node involvement in breast carcinoma.Pathologic diagnosis of breast cancer patients: evolution of the traditional clinical-pathologic paradigm toward "precision" cancer therapy.Continuous measurement of breast tumour hormone receptor expression: a comparison of two computational pathology platforms.Patterns of change over time and history of the inflammatory potential of diet and risk of breast cancer among postmenopausal womenTumor Phenotype and Gene Expression During Early Mammary Tumor Development in Offspring Exposed to Alcohol In Utero.An optimized image analysis algorithm for detecting nuclear signals in digital whole slides for histopathology.Association of three single nucleotide polymorphisms of ESR1with breast cancer susceptibility: a meta-analysis.Can algorithmically assessed MRI features predict which patients with a preoperative diagnosis of ductal carcinoma in situ are upstaged to invasive breast cancer?Improving accuracy of breast cancer biomarker testing in India.Blood-derived non-extracellular vesicle proteins as potential biomarkers for the diagnosis of early ER+ breast cancer and detection of lymph node involvement.
P2860
Q26777676-7D64A801-86DE-450D-91F2-7A924828846FQ33664216-E169E7B4-6B72-4EA6-9951-61CC994C7D62Q33887173-4090358A-02B4-4A9F-B3D3-08AB983613D3Q35810073-B3C699B3-8255-4803-9A58-F27D282003D1Q36057132-CE024DED-A466-413D-A2C7-848C8E38DF3EQ36964372-BFF49A68-93C1-4C29-8870-24FFA877A98DQ37593925-735B6530-C1D0-4270-973D-2C2EA961CE6BQ39187437-8579DBCE-69B6-4565-906F-E5900BE16476Q39301594-2863A795-2850-4D7A-814D-CA30E03FB66EQ39542725-85A82F9A-230D-4852-A6A3-05044DAD2E44Q39636088-1A82D017-B3E8-49D4-B805-76C877A01B36Q40466552-278CEC58-7455-44A9-81B4-C1AB279853F8Q42219383-15CDE33D-180F-450D-909D-2A42E688E041Q47978876-D5E48640-AFDD-40E7-A1E3-DB9E85166D99Q50056206-0CDA2BD3-2ED4-49EB-89A0-3BC21F37B88EQ55284547-8E5D525C-E0B9-4BED-8C37-3DB0050B6D1C
P2860
Predictive markers in breast cancer: An update on ER and HER2 testing and reporting.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Predictive markers in breast cancer: An update on ER and HER2 testing and reporting.
@en
type
label
Predictive markers in breast cancer: An update on ER and HER2 testing and reporting.
@en
prefLabel
Predictive markers in breast cancer: An update on ER and HER2 testing and reporting.
@en
P1476
Predictive markers in breast cancer: An update on ER and HER2 testing and reporting
@en
P2093
Laura C Collins
P304
P356
10.1053/J.SEMDP.2015.02.011
P577
2015-02-07T00:00:00Z